Johnson & Johnson Vision, Singapore's A*STAR forge partnership to set up digital eye health consortium

刊登時間

Almost two-thirds of patients with moderate to severe vision impairment globally come from East, South, and Central Asia. Specifically, South Asia has the highest prevalence of moderate to severe vision impairment at 17.5% and mild vision impairment at 12.2%, a study found. Most of these impairments, according to A*STAR, are caused by preventable conditions.

Johnson & Johnson Vision, the eye health unit of Johnson & Johnson MedTech, has signed a memorandum of understanding with the Agency for Science, Technology and Research, an agency under Singapore's Ministry of Trade and Industry, to jointly establish an Eye Health Digital Innovation Consortium. 

Seen as a first of its kind in Asia-Pacific, the consortium will set up public-private partnerships between eye care professionals, academia, and the eye health industry. These partnerships will jointly identify and prioritise the most pressing eye health needs within the region and develop innovations addressing these needs.

【MORE】
資料出處: Healthcare IT News